|
HS Code |
402431 |
| Cas Number | 102-64-9 |
| Iupac Name | 3,5-Dimethoxyaniline |
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.18 g/mol |
| Appearance | Light yellow to brown solid |
| Melting Point | 62-66 °C |
| Boiling Point | 285-287 °C |
| Density | 1.13 g/cm³ |
| Solubility In Water | Slightly soluble |
| Refractive Index | 1.574 |
| Smiles | COC1=CC(N)=CC(OC)=C1 |
| Pubchem Cid | 77443 |
As an accredited 3,5-Dimethoxyaniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 100-gram amber glass bottle, screw-capped, labeled "3,5-Dimethoxyaniline," chemical formula, CAS number, and hazard warnings displayed. |
| Shipping | 3,5-Dimethoxyaniline is shipped in tightly sealed containers, stored in a cool, dry, and well-ventilated area. Containers are clearly labeled and handled according to local and international regulations for chemical transport. Personnel must use appropriate protective gear during handling to prevent exposure and ensure safety during storage and transit. |
| Storage | 3,5-Dimethoxyaniline should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from sources of ignition and incompatible substances such as strong oxidizers and acids. Protect from light and moisture. Proper labeling and secondary containment are recommended to prevent accidental spills and ensure safe handling and storage conditions. |
Applications of 3,5-Dimethoxyaniline in Industrial Manufacturing3,5-Dimethoxyaniline serves as a key intermediate in a range of high-value downstream sectors, delivering reliable performance in advanced chemical synthesis and specialized manufacturing environments. The following application scenarios demonstrate industrial integration of this raw material within established production chains where documented regulatory oversight and proven compatibility support its sustained global adoption. 1. Pharmaceutical Intermediate SynthesisPharmaceutical manufacturers incorporate 3,5-dimethoxyaniline as a building block in the synthesis of active pharmaceutical ingredients (APIs), particularly for the preparation of substituted anilines required in anti-inflammatory and antipyretic drug classes. The aromatic amine moiety delivers selectivity in electrophilic aromatic substitution, with carefully monitored addition rates to ensure purity and minimize side reactions during multistep transformations under GMP environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical SynthesisChemical crop protection companies employ this raw material for the targeted synthesis of particular aniline-derived herbicides and fungicides. Its electron-donating methoxy substituents allow precise control during aromatic nitration, halogenation, and diazotization steps critical for downstream agrochemical activity, with process design based on field efficacy data and regulatory residue limits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Dye and Pigment Intermediate ProductionProducers of specialty dyes and pigments rely on this material to introduce specific methoxy patterns in aromatic rings for improved chromophore stability. It directly participates in azo dye coupling and oxidative cyclization, where exact dosing impacts shade consistency, solubility, and UV resistance of the final pigment dispersions. Quality management enforces batch reproducibility and chromatographic purity throughout multi-ton scale manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis for Electronic MaterialsManufacturers in the electronic chemicals sector leverage this amine for tailoring functional moieties within high-purity organic semiconductors and dye-sensitized solar cell (DSSC) components. The compound’s dual methoxy groups modulate electron density, supporting reliable performance in functional small molecules and specialty polyanilines applied in emerging optoelectronic devices, with attention to contamination control at sub-ppm levels. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Organic Synthesis for Perfume Ingredient IntermediatesCompanies focused on fragrance raw material synthesis incorporate 3,5-dimethoxyaniline into intermediates for musk and anisic compounds. The compound supports regioselective substitution and esterification enabling downstream olfactory-active molecules, with controlled addition crucial for purity and olfactory profile targeting in large-scale aroma chemical production lines governed by IFRA standards and European safety regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3,5-Dimethoxyaniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our facility, we have watched 3,5-Dimethoxyaniline become one of the go-to intermediates in synthesis across several sectors. Our daily production emphasizes the demands of pharmaceuticals and agricultural compounds but also notices its growing footprint in dyes, specialty polymers, and chemical research. This aniline derivative, known by CAS number 104-92-7, comes up in both new research discussions and established multi-ton batch orders. Its two methoxy groups at the 3- and 5-positions on the aniline ring unlocks pathways that plain aniline or mono-methoxylated anilines can’t fulfill.
Each molecule can participate in fine-tuned reactions. In our reactors, purity and positional selectivity matter—down to the last decimal—and that drives discussions about quality with both established partners and new clients. Its white to off-white crystalline appearance may seem unremarkable, but chemists recognize the stability and reactivity made possible by those methoxy groups. Over years of working with this compound, we have refined our processes to squeeze out any minor isomeric impurities or colored byproducts. Feedback often touches on reliable melting range, low residual moisture, and tight GC area purity.
One thing we encounter in our work is the comparison between 3,5-Dimethoxyaniline and its regioisomers, or even with simpler anilines. The dual methoxy pattern in the meta-positions sometimes draws confusion from those only familiar with mono-substituted types, like 4-methoxyaniline. Mono-methoxy anilines usually push the electron-donating effect at a single site and open up a different profile in coupling reactions. By contrast, the 3,5-pattern yields milder reactivity, but introduces more pronounced selectivity in certain syntheses. We have seen custom dyestuff chemistries count on this difference. A handful of organic electronics teams now seek out the symmetrical substitution for thin-film processing.
Operationally, producing this compound involves careful temperature controls and timing during methylation and amination stages. Overheating or overexpression of reagents can tip the balance toward unwanted regioisomers. Every batch is carefully monitored for signs of these byproducts, which can alter not just color, but the solubility profile vital for downstream applications. Tight process controls let us deliver a final product with predictable solubility in organic solvents—something both formulation teams and pilot plant engineers appreciate.
In recent years, we have worked with a growing roster of medicinal chemistry labs that use 3,5-Dimethoxyaniline as a starting block for anti-infective and anti-tumor agents. The methoxy groups offer protection against premature oxidation or unwanted deamination, and their influence on electronic structure sometimes opens up new binding motifs in lead discovery campaigns. Downstream, we periodically receive requests for kilogram-scale supply with custom particle sizing or purification levels, especially as regulatory requirements shift.
On the pigments and dyes side, our partners rely on the reproducibility of our batches, especially when scaling from grams to pallet-sized quantities. Poorly controlled manufacturing of similar compounds—like 2,4-dimethoxyaniline or 3,4,5-trimethoxyaniline—can lead to visible shade shifts or reduced batch stability in colorant formulations. This underlines the value in working with manufacturers who monitor every stage, from initial raw material selection to final packaging.
Production of 3,5-Dimethoxyaniline on a multi-ton scale brings unique challenges compared to more commoditized aromatic amines. Our tanks see repeated stress testing during the amination process; inconsistent heat transfer or reagent feed can compromise yield. Process optimization efforts over the past decade have given us insights not only for this specific product but for broader aniline derivative manufacture.
This is a compound that rarely sees direct end-use without transformation. Instead, it acts as a vital building block. In our experience, clients often modify it through acylation, diazotization, or coupling—each operation placing fresh demands on the raw material’s purity. A dye manufacturer, for example, addressed us with issues caused by trace levels of 3,4-dimethoxyaniline in a competitor’s material, which complicated azo coupling yields. By tightening our fractionation protocols, we helped them stabilize their finished color consistency.
Many in the marketplace treat all methoxyanilines as interchangeable. Our technical support teams field recurring questions about the difference between, say, 3-methoxyaniline, 4-methoxyaniline, or 3,5-dimethoxyaniline. In day-to-day plant operations, these differences are significant. Electron density shifts alter their participation in electrophilic substitution, which in turn affects everything from reactivity to heat stability of downstream products. The symmetrical substitution on the 3,5-variant can mean less interference in multi-step synthesis—something process chemists engaged in scale-up often cite as a key reason for selecting this material.
Older grades produced with less strict controls frequently caused trouble in pharmaceutical synthesis. In contrast, our modern approach delivers reproducible batches with tightly managed side products and minimal colorants formation. Over the years, more medicinal chemistry projects have chosen 3,5-dimethoxyaniline over former favorites due to its improved reliability and influence on pharmacophoric development.
Working with aryl amines always requires due diligence around worker safety and environmental release. In our factory, we incorporate enclosed handling and high-efficiency scrubbing to minimize emission risks. Historical practices in some regions cut corners with vented systems, spreading odors and possible health effects. By investing in recovery and containment, we meet new regulatory developments in most export markets and have helped clients facing chemical safety audits to explain sourcing and compliance with ease.
Logistics matter. As the raw aniline derivatives see global demand spikes, we’ve noticed transport regulation changes tied to environmental performance and hazardous material categories. We lean into our relationships with vetted forwarders and maintain up-to-date compliance protocols to avoid shipment delays at customs. Companies sourcing from casual traders or unchecked exporters often find themselves at odds with customs and port officials—delays that have never helped a production schedule.
Through years of supplying 3,5-Dimethoxyaniline, we have developed a responsive model to customer feedback. Dye houses may ask for tighter control of moisture, while pilot pharma plants flag the need for reduced heavy metals or ultralow residual solvents. Each feedback point feeds directly into process improvements and batch test regimes. In the early days, most communication focused on spec sheets and Certificates of Analysis. Lately, dialogue has shifted toward robust documentation for REACH, TSCA, and other international chemical registration regimes.
In R&D collaborations, we’ve witnessed how incremental purity improvements let advanced syntheses push yield envelopes even further. Some partners use our aniline derivative as a stepping stone in complex heterocycle development; others explore its application in agrochemical formulation where adjuvant stability is essential. Where we see repeat orders and expanded joint development, it reflects how our practical, factory-level optimization enables their innovation.
Day-to-day production involves more than quality checkpoints and analytics. In our facility, operators are trained to handle this compound through contained systems, limiting potential exposure. Waste streams from methylation or amination sometimes contain minor side-products that require dedicated treatment. Overhead mitigation costs, including solvent recovery or distillation, factor into our pricing—but ensure less environmental risk for us and downstream users.
Compared with older decades, automated packaging has reduced both contamination risk and exposure incidents. Today’s packed drums or bags keep out atmospheric moisture and cross-contamination with other aromatic amines. Those who’ve worked in chemical warehouses know the frustration that comes from poorly sealed packaging—moisture pick-up, color changes, and even clumping can ruin a downstream process and complicate scale-up.
We’ve learned that customer requirements rarely stand still. A few years ago, typical orders sought purity above 98 percent and modest control on water content. Since then, advance in API development and high-performance dyes sparked requests for even tighter specifications—upward of 99 percent and water well below 0.1 percent. Mass spec and NMR checks are more common, demanded not just by regulatory agencies, but also by the internal QC teams of our advanced customers.
There’s clear competitive pressure to continually refine both analytical tools and isolation techniques. In our plant, that means new GC setups and the use of deeper vacuum for final drying. Older purification frameworks sufficed for industrial colorants but not for pharmaceutical or high-tech polymer intermediates. We test for aldehydic and nitro impurities, as even minor traces can catalyze downstream decomposition.
Chemical manufacturing faces new scrutiny from global buyers, from scrutiny over solvent use to local regulatory registration. Our ongoing investment in solvent reuse cuts both emissions and costs, responding to questions from end users about carbon footprint. Every ton of 3,5-Dimethoxyaniline set aside for re-blend means less waste and avoids the inefficiency of single-use solvents that dominated industry practices of the past.
Some customers now list supply chain robustness as a top concern, especially after witnessing recent logistics bottlenecks. Our response is local warehousing in multiple regions and buffer stocks at key depots. This lets us ride out delays in upstream feedstocks or restrictions in port traffic. Shipments of uncontrolled or grey-market materials often risk flagging at customs, so traceable batches with full quality documentation have become a differentiator.
We see orders rolling in from pharmaceuticals, dyestuffs, intermediate manufacturers, agrochemical producers, and research institutions. Common stories from users include improved batch-to-batch consistency and fewer downstream issues compared with generic grades sourced from less controlled producers. Pharma groups highlight the ability to scale up from small-lab to pilot plant without facing impurities that block downstream chemistry. Dyestuff companies appreciate the reliable chromophore formation, with clean transitions in hue and minimal unexpected color shifts.
Custom synthesis teams value not having to revisit raw material qualification with every shipment. In our experience, the more meticulous the downstream process, the more crucial fully characterized, well-handled starting materials. Any lapse at our end magnifies as expensive cGMP or regulatory-quality syntheses down the line.
We have addressed challenges by building both technical and human capacity. Training staff to monitor every stage—the methylation control, amination timing, post-reaction clean-ups—has cut incidents of off-spec batches. Auditing supply chains has weeded out unreliable or unsafe raw reagent vendors, boosting both consistency and confidence for stakeholders further down the line.
Some partners want ever-improving documentation—mass spectrometry scans, heavy metals assessments, full spectral data, detailed impurity profiles. We have opened up data sharing portals and standardized reporting interfaces, because delays and hiccups often come from mismatched paperwork, not just missed specs.
Supply disruptions have led us to lean towards vertical integration for certain critical inputs. Bringing feedstock processing in-house means less vulnerability to market swings triggered by upstream shortages or regulation in distant regions. These sorts of precautions keep the flow of 3,5-Dimethoxyaniline steady in a world of shifting geopolitical risk.
No two compounds serve all markets equally well. Feedback from long-term partners makes clear: reliable production and transparency in manufacturing ensure success, not just on paper but across thousands of kilograms in real-world processes. 3,5-Dimethoxyaniline may be a single line item in a complex synthesis, but small differences upstream can mean major differences in yield, cost, and quality outcomes downstream. The experience of hands-on manufacturing brings home these principles time and again.